Abbott’s strong medical device sales drive upbeat quarter as surgeries rebound
By Khushi Mandowara and Pratik Jain (Reuters) -Abbott Laboratories on Thursday beat quarterly profit expectations as a rebound in surgical procedure volumes drove demand for medical devices despite high inflation-driven costs, sending shares up by nearly 4%. Demand for medical devices and non-COVID-19 testing is expected to rise this year, as older adults in particular get more comfortable visiting hospitals and staffing shortages at those facilities ease. Abbott CEO Robert […]